Study summary

The purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis (RA) subjects

Additional Study Details

Phase
2
Product
N/A
Product
peficitinib
Placebo
Type
Interventional
Masking
Triple (Participant, Care Provider, Outcomes Assessor)
Enrollment number
289
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Rethy Pal Korhaz es Rendelointezet
    Bekescsaba, Hungary, 5600
    Completed
    Achieve Clinical Research, LLC
    Birmingham, AL, United States, 35216
    Completed
    Health Research of Oklahoma
    Oklahoma City, OK, United States, 73103
    Completed
    Cliditer S.A. de C.V.
    México, Distrito Federal, Mexico, 6700
    Completed
    Budai Irgalmasrendi Korhaz
    Budapest,, Hungary, 1027
    Completed
    NZOZ Centrum Medyczne ProMiMed
    Krakow, Poland, 31-637
    Completed
    MEDICAL PLUS, s.r.o. or REVMACENTRUM UH, s.r.o.
    Uherske Hradiste, Czech Republic, 68601
    Completed
    MHAT "Sv. Ivan Rilski"
    Sofia, Bulgaria, 1612
    Completed
    Arthritis Associates
    Orlando, FL, United States, 32804
    Completed
    Jacksonville Center for Clinical Research
    Jacksonville, FL, United States, 32216
    Completed
    Pacific Arthritis Center Medical Group
    Santa Maria, CA, United States, 93454
    Completed
    Stanford University School of Medicine
    Palo Alto, California, United States, 94304
    Completed
    Desert Medical Advances
    Palm Desert, CA, United States, 92260
    Completed
    Orszgos Reumatolgiai s Fizioterpis Intzet
    Budapest, Hungary, 1027
    Completed
    Kenezy Hospital Institute of Clinical Pharmacology
    Debrecen, Hungary, H-4043
    Completed
    Clincal Research Center of Reading
    Wyomissing, PA, United States, 19610
    Completed
    PV-MEDICAL s.r.o.
    Zlin, Czech Republic, 760 01
    Completed
    Zespol Poradni Specjalistycznych, REUMED sp. Zo.o
    Lublin, Poland, 20-582
    Completed
    The Center for Rheumatology and Bone Research
    Wheaton, MD, United States, 20902
    Completed
    PMG Research
    Hickory, NC, United States, 28602
    Completed
    Center for Arthritis and Osteoporosis
    Elizabethtown, KY, United States, 42701
    Completed
    Szpital Uniwersytecki nr. 2 im. Dr. Jana Biziela
    Bydgoszcz, Poland, 85-168
    Completed
    Mountain State Clinical Research
    Clarksburg, West Virginia, United States, 26301
    Completed
    Altoona Center for Clinical Research
    Duncansville, PA, United States, 16635
    Completed
    Revita Clinic Rheumatology
    Budapest, Hungary, 1027
    Completed
    Centro de Investigacion Clinica de Morelia, S.C.
    Morelia, Mexico, 58070
    Completed
    Revmatologicky ustav
    Praha 2, Czech Republic, 128 50
    Completed
    University of California San Diego
    LaJolla, CA, United States, 92093-0943
    Completed
    ARS Rheumatica
    Warszawa, Poland, 02-653
    Completed
    MHAT Plovdiv AD
    Plovdiv, Bulgaria, 4003
    Completed
    Revmatologicka ambulance
    Praha-Nusle, Czech Republic, 140 00
    Completed
    Deerbrook Medical Asssociates
    Vernon Hills, IL, United States, 60061
    Completed
    Arthritis Associates of Colorado Springs
    Colorado Springs, Colorado, United States, 80910
    Completed
    Dr Javier Orozco Alcala Private Doctor´s office
    Guadalajara, Mexico, 44650
    Completed
    Rheumatology Consultants, PLLC
    Knoxville, TN, United States, 37909-1907
    Completed
    Austin Rheumatology Research PA
    Austin, TX, United States, 78705
    Completed
    Illinois Bone & Joint Institute; LLC
    Morton Grove, IL, United States, 60053
    Completed
    MHAT Burgas
    Burgas, Bulgaria, 8000

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?